Indicia Production acquires METIS Biotechnologies
Indicia Production, a company specialized in the manufacture of ready-to-use culture media and sterile liquid products, announces the acquisition of METIS Biotechnologies, a company that develops, produces and markets rapid microbiological analysis solutions using flow cytometry. The financial terms of the transaction have not been disclosed.
METIS Biotechnologies’ analytical solutions can be automated from sampling to results rendering. They are applicable for the pharmaceutical, food processing and cosmetics industries. The instruments and reagents on offer allow companies to carry out in-situ analysis, such as on the sterility of UHT dairy products, fruit juices and other food products, also the detection of acidophilic and acid-resistant floras in fruit juices as well as bacteria, yeasts and molds in cosmetic products.
This acquisition enables Indicia Production to become a major player on the market by extending its current traditional microbiological media offering with the fast and tailored microbiological analysis technology using flow cytometry, developed by METIS Biotechnologies. This will allow the company’s customers in the agrifood and cosmetics industries to improve their reactivity in the control of production.
“We could not have found a better buyer than Indicia Production, a leader in custom production and high-quality ready-to-use microbiological culture media. The acquisition will allow us to offer a complete range of microbiological analysis to our customers,” said Bruno Vedrine, founder of METIS, now chief scientific officer at Indicia and director of the Limoges site. “This is a particularly exciting step for the future of METIS Biotechnologies as it will enable us to strengthen our sales force in France and abroad.”
“The integration of METIS Biotechnologies will strengthen Indicia’s presence on the industrial microbiological control market, in which we have been present since 2008. The technology developed by METIS is now fully operational and meets the needs of the industry,” said Stéphane Legastelois, CEO of Indicia Production. “In addition, METIS’ know-how in custom solutions will complement our services. This acquisition is part of our strategy to develop through external growth, with a special focus on vertical integration in the field of industrial microbiology.”
Following the acquisition, the consolidated company will operate with 57 employees. Its turnover is estimated to reach €8 million ($8.35M) in 2017.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Last viewed contents
PolyTherics to collaborate with UCL to develop a new treatment for ‘sticky blood’ syndrome
A taste for plastic - Discovered for the first time: New deep-sea enzyme breaks down PET plastic
From smoky skies to a green horizon: Scientists convert fire-risk wood waste into biofuel - A simplified new process transforms wood waste from agriculture and forest management into ethanol
Generex Awarded New Patent in Morocco
Images of antibodies working together against malaria
Chemie.DE Information Service's 10th Anniversary: an Online Success Story
Evocatal GmbH Closes New Financing Round
Eppendorf opens new site in Singapore - Targeted strengthening of customer focus with high-tech laboratory for pipette calibration and extensive range of high-quality laboratory services
Evotec enters partnership with Vienna start-up - Quantro exploits innovative functional-genetic and transcriptomic technologies to address “undruggable” targets
BluCon Biotech and LG Chem enter into unique investment agreement - BluCon Biotech's technology has the potential to be a disruptive game changer in the world's plastics market
